Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shorter proton blasts may boost lung cancer survival

NCT ID NCT01770418

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 23 times

Summary

This study tests a new way to give proton radiation for stage II-III non-small cell lung cancer. Instead of daily low doses over many weeks, patients get higher doses over a shorter time (hypofractionation) along with standard chemotherapy. The goal is to find the safest high dose and see if it helps more people live at least one year. About 32 adults with good performance status are taking part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG NEOPLASMS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hampton University Proton Therapy Institute

    Hampton, Virginia, 23666, United States

  • Maryland Proton Treatment Center

    Baltimore, Maryland, 21201, United States

  • Northwestern Medicine Chicago Proton Center

    Warrenville, Illinois, 60555, United States

  • Oklahoma Proton Center

    Oklahoma City, Oklahoma, 73142, United States

  • Princeton ProCure Management LLC

    Somerset, New Jersey, 08873, United States

  • University of Florida Proton Therapy Institute

    Jacksonville, Florida, 32206, United States

Conditions

Explore the condition pages connected to this study.